From owner-ietf-schema-reg@mail.imc.org  Tue Jan 16 22:10:36 2001
Received: from ns.secondary.com ([208.184.76.39])
	by ietf.org (8.9.1a/8.9.1a) with SMTP id WAA26791
	for <schema-archive@odin.ietf.org>; Tue, 16 Jan 2001 22:10:35 -0500 (EST)
Received: by ns.secondary.com (8.9.3/8.9.3) id SAA10089
	for ietf-schema-reg-bks; Tue, 16 Jan 2001 18:57:36 -0800 (PST)
Received: from webserver.onlineevents.com.au ([203.111.80.201])
	by ns.secondary.com (8.9.3/8.9.3) with ESMTP id SAA10071;
	Tue, 16 Jan 2001 18:57:31 -0800 (PST)
From: bk12bk27@yahoo.com
Received: from max1-34.losangeles.corecomm.net by webserver.onlineevents.com.au with SMTP (Microsoft Exchange Internet Mail Service Version 5.0.1459.44)
	id C0CGL6NV; Wed, 17 Jan 2001 14:54:35 +1100
DATE: 16 Jan 01 6:44:45 PM
Message-ID: <T9d1T8dXw3i2o91R4P>
SUBJECT: RE; THANK YOU 
Sender: owner-ietf-schema-reg@mail.imc.org
Precedence: bulk
List-Archive: <http://www.imc.org/ietf-schema-reg/mail-archive/>
List-ID: <ietf-schema-reg.imc.org>
List-Unsubscribe: <mailto:ietf-schema-reg-request@imc.org?body=unsubscribe>

Dear Friend and Partner, 

Think of all the things you could do if you had more free time and money wasn't an 
object

             What kind of car would you be driving? 

                     Where would you live? 

                           Where would you go on vacation? 
  

Now, for a limited time, 300+ money making and saving secrets can be yours for less 
than $10.00. 

Click here http://www.300moneysecrets.com/    and ORDER NOW!!!!!!!!!!!!!! 
  

Get information now, that could make you millions!!!! 
  


 ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** 

To be removed from our mailing list, please email sandywho1212@yahoo.com All REMOVE requests AUTOMATICALLY honored upon receipt. PLEASE understand that any effort to disrupt, close or block this REMOVE account can only result in difficulties for others wanting to be removed     from our mailing list as it will be impossible to take anyone off the list if the remove instruction can not be received.



From owner-ietf-schema-reg@mail.imc.org  Wed Jan 17 14:29:58 2001
Received: from ns.secondary.com ([208.184.76.39])
	by ietf.org (8.9.1a/8.9.1a) with SMTP id OAA24691
	for <schema-archive@odin.ietf.org>; Wed, 17 Jan 2001 14:29:57 -0500 (EST)
Received: by ns.secondary.com (8.9.3/8.9.3) id LAA24334
	for ietf-schema-reg-bks; Wed, 17 Jan 2001 11:12:48 -0800 (PST)
Received: from webserver.onlineevents.com.au ([203.111.80.201])
	by ns.secondary.com (8.9.3/8.9.3) with ESMTP id LAA24291;
	Wed, 17 Jan 2001 11:12:41 -0800 (PST)
From: bk12bk27@yahoo.com
Received: from max1-34.losangeles.corecomm.net by webserver.onlineevents.com.au with SMTP (Microsoft Exchange Internet Mail Service Version 5.0.1459.44)
	id C0CGL6NV; Wed, 17 Jan 2001 14:54:35 +1100
DATE: 16 Jan 01 6:44:45 PM
Message-ID: <T9d1T8dXw3i2o91R4P>
SUBJECT: RE; THANK YOU 
Sender: owner-ietf-schema-reg@mail.imc.org
Precedence: bulk
List-Archive: <http://www.imc.org/ietf-schema-reg/mail-archive/>
List-ID: <ietf-schema-reg.imc.org>
List-Unsubscribe: <mailto:ietf-schema-reg-request@imc.org?body=unsubscribe>

Dear Friend and Partner, 

Think of all the things you could do if you had more free time and money wasn't an 
object

             What kind of car would you be driving? 

                     Where would you live? 

                           Where would you go on vacation? 
  

Now, for a limited time, 300+ money making and saving secrets can be yours for less 
than $10.00. 

Click here http://www.300moneysecrets.com/    and ORDER NOW!!!!!!!!!!!!!! 
  

Get information now, that could make you millions!!!! 
  


 ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** REMOVE ** 

To be removed from our mailing list, please email sandywho1212@yahoo.com All REMOVE requests AUTOMATICALLY honored upon receipt. PLEASE understand that any effort to disrupt, close or block this REMOVE account can only result in difficulties for others wanting to be removed     from our mailing list as it will be impossible to take anyone off the list if the remove instruction can not be received.



From owner-ietf-schema-reg@mail.imc.org  Mon Jan 22 20:02:10 2001
Received: from ns.secondary.com ([208.184.76.39])
	by ietf.org (8.9.1a/8.9.1a) with SMTP id UAA18434
	for <schema-archive@odin.ietf.org>; Mon, 22 Jan 2001 20:02:10 -0500 (EST)
Received: (from majordomo@localhost)
	by ns.secondary.com (8.9.3/8.9.3) id QAA21696
	for ietf-schema-reg-bks; Mon, 22 Jan 2001 16:49:29 -0800 (PST)
Received: from cins.hanyang.ac.kr ([166.104.204.187])
	by ns.secondary.com (8.9.3/8.9.3) with ESMTP id QAA21626;
	Mon, 22 Jan 2001 16:47:24 -0800 (PST)
From: emed22@libero.it
Received: by cins.hanyang.ac.kr id JAA305538; Tue, 23 Jan 2001 09:27:53 +0900 (KST)
Subject: Obtain Biotech IPOs!    13
Date: Mon, 22 Jan 2001 19:51:16
Message-Id: <53.644352.589899@unknown>
Reply-To: emed22@libero.it
Mime-Version: 1.0
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
X-MIME-Autoconverted: from 8bit to quoted-printable by cins.hanyang.ac.kr id JAA305538
Sender: owner-ietf-schema-reg@mail.imc.org
Precedence: bulk
List-Archive: <http://www.imc.org/ietf-schema-reg/mail-archive/>
List-ID: <ietf-schema-reg.imc.org>
List-Unsubscribe: <mailto:ietf-schema-reg-request@imc.org?body=unsubscribe>
Content-Transfer-Encoding: quoted-printable


<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=3D(0073)file://C:\WINDOWS\Temporary%20Internet%20File=
s\OLKC225\A0007-1-A2-00.html -->
<HTML><HEAD><TITLE></TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-1=
252">
<META content=3D"Microsoft FrontPage 4.0" name=3DGENERATOR>
<META content=3DFrontPage.Editor.Document name=3DProgId></HEAD>
<BODY bgColor=3D#cccccc>
<DIV align=3Dcenter>
<TABLE borderColor=3D#003366 cellSpacing=3D5 borderColorDark=3D#003366 ce=
llPadding=3D14=20
width=3D550 borderColorLight=3D#003366 border=3D2>
  <TBODY>
  <TR>
    <TD width=3D"100%" bgColor=3D#ffffff>
      <P class=3DMsoBodyText align=3Dcenter><B><FONT face=3DVerdana color=
=3D#003399=20
      size=3D4>Help Beta Test Our Site and Be Eligible to Purchase Shares=
 of=20
      Future IPOs In Which We Participate**</FONT></B></P>
      <P class=3DMsoBodyText style=3D"TEXT-ALIGN: left" align=3Dleft><FON=
T face=3DArial=20
      size=3D2>eMedsecurities has selected you as a possible participant =
to help=20
      test our online stock-trading engine for knowledge-based investing =
in the=20
      life sciences.&nbsp; For your cooperation, <B>you will be eligible =
to purchase=20
      shares of future IPOs</B> in which we participate, for as long as y=
ou=20
      maintain your account with us.&nbsp; This is limited to only <B>50 =
qualified=20
      testers!&nbsp; </B><a href=3D"mailto:emedemed1@libero.it">Request M=
ore
      Information</a>.**</FONT></P>
      <P class=3DMsoBodyText align=3Dcenter><B><FONT face=3DVerdana color=
=3D#003399=20
      size=3D3>eMedsecurities=85 The Cure for the Common Portfolio!</FONT=
></B></P>
      <P class=3DMsoBodyText style=3D"TEXT-ALIGN: left" align=3Dleft><FON=
T face=3DArial=20
      size=3D2>eMedsecurities provides you with a wealth of information, =
all=20
      compiled in a single, easy-to-use resource.&nbsp; Learn about new r=
esearch=20
      and upcoming treatments for diabetes, glaucoma, cataract, obesity a=
nd much more.&nbsp; Obtain critical investment information about the=20
      companies that are developing these treatments.&nbsp; eMedsecuritie=
s empowers=20
      you to make more informed investment decisions.&nbsp; <a href=3D"ma=
ilto:emedemed1@libero.it">Request
      More Information</a>.**</FONT></P>
      <P class=3DMsoNormal><B><FONT face=3DArial size=3D2>Participation i=
n
      eMedsecurities's Beta Test allows you:</FONT></B></P>
      <UL>
        <LI>
        <P class=3DMsoNormal=20
        style=3D"mso-list: l1 level1 lfo2; tab-stops: list .5in; line-hei=
ght: 100%; margin-top: 0; margin-bottom: 0"><B><FONT=20
        face=3DArial size=3D2 color=3D"#003399">Eligibility to purchase s=
hares of IPOs in which=20
        eMedsecurities participates for as long as you maintain your=20
        account**</FONT></B> </P>
        <LI>
        <P class=3DMsoNormal=20
        style=3D"mso-list: l1 level1 lfo2; tab-stops: list .5in; line-hei=
ght: 100%; margin-top: 0; margin-bottom: 0"><B><FONT=20
        face=3DArial size=3D2 color=3D"#003399">Valuable research of the =
entire product=20
        pipeline of companies, including stages of clinical development, =
by=20
        industry or specific disease</FONT></B> </P>
        <LI>
        <P class=3DMsoNormal=20
        style=3D"mso-list: l1 level1 lfo2; tab-stops: list .5in; line-hei=
ght: 100%; margin-top: 0; margin-bottom: 0"><B><FONT=20
        face=3DArial size=3D2 color=3D"#003399">Useful information about =
industry trends, recent=20
        developments and upcoming IPOs</FONT></B> </P>
        <LI>
        <P class=3DMsoNormal=20
        style=3D"mso-list: l1 level1 lfo2; tab-stops: list .5in; line-hei=
ght: 100%; margin-top: 0; margin-bottom: 0"><B><FONT=20
        face=3DArial size=3D2 color=3D"#003399">Commitment to customer se=
rvice featuring=20
        our Live Customer Service Online</FONT></B> </P>
        <LI>
        <P class=3DMsoNormal=20
        style=3D"mso-list: l1 level1 lfo2; tab-stops: list .5in; line-hei=
ght: 100%; margin-top: 0; margin-bottom: 0"><B><FONT=20
        face=3DArial size=3D2 color=3D"#003399">Dedication to fast trade =
executions at the best=20
        possible price.</FONT></B> </P>
      </UL>
      <P align=3Dleft><FONT face=3DArial size=3D2>The following guideline=
s will=20
      explain what we expect from an eMedsecurities Beta Tester:</FONT></=
P>
      <UL>
        <LI>
        <P align=3Dleft style=3D"line-height: 100%; margin-top: 0; margin=
-bottom: 0"><FONT face=3DArial size=3D2>Open a funded eMedsecurities=20
        account</FONT> </P>
        <LI>
        <P align=3Dleft style=3D"line-height: 100%; margin-top: 0; margin=
-bottom: 0"><FONT face=3DArial size=3D2>Visit our online trading site onc=
e=20
        a week</FONT> </P>
        <LI>
        <P align=3Dleft style=3D"line-height: 100%; margin-top: 0; margin=
-bottom: 0"><FONT face=3DArial size=3D2>Execute trades through our
        Web=20
        site in accordance with your normal practice</FONT> </P>
        <LI>
        <P align=3Dleft style=3D"line-height: 100%; margin-top: 0; margin=
-bottom: 0"><FONT face=3DArial size=3D2>Submit feedback to eMedsecurities=
's development team through a questionnaire sent via=20
        email</FONT> </P>
        <LI>
        <P align=3Dleft style=3D"line-height: 100%; margin-top: 0; margin=
-bottom: 0"><FONT face=3DArial size=3D2>Provide us with additional=20
        feedback regarding the site as needed.</FONT> </P></LI></UL>
      <P align=3Dleft><FONT face=3DArial size=3D2>The test is limited to =
only 50 Beta=20
      Testers so sign up now to be considered!&nbsp; <a href=3D"mailto:em=
edemed1@libero.it">Request
      More Information</a>.**</FONT>=20
      <P align=3Dleft><B><FONT face=3DArial size=3D2>Please note:</FONT><=
/B><FONT=20
      face=3DArial size=3D2> All applications for the Beta Test must be s=
ubmitted by
      January 25, 2001 to be considered.</FONT>=20
      <P align=3Dleft><FONT face=3DArial size=3D2><SPAN=20
      style=3D"mso-bidi-font-size: 12.0pt; mso-fareast-font-family: Times=
 New Roman; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bi=
di-language: AR-SA">Please=20
      be advised that your information will stay in our proprietary datab=
ase and=20
      will not be sold, traded, given or otherwise provided to outside ve=
ndors.&nbsp;
      We respect your privacy.</SPAN></FONT>=20
      <P align=3Dleft>=20
      <P align=3Dleft><FONT face=3DArial size=3D1><SPAN=20
      style=3D"mso-fareast-font-family: Times New Roman; mso-ansi-languag=
e: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">By=20
      submitting your information, you implicitly state that this is some=
thing=20
      that interests you and that you<br>
      agree to receive periodic emails from=20
      eMedsecurities.</SPAN></FONT>=20
      <P class=3DMsoNormal><FONT face=3DArial size=3D1>Research indicated=
 that you=20
      might benefit from our offer.&nbsp; To be removed instantly and per=
manently from=20
      our database, simply <a href=3D"mailto:emed22@libero.it">click here=
</a>.&nbsp;
      We respect=20
      all removal requests.</FONT></P><FONT face=3DArial size=3D1>**<B> R=
estrictions=20
      Apply:</B>&nbsp; <SPAN style=3D"COLOR: red"><B>Beta test not open t=
o residents
      of HI, IL, MI, MN, NE, NH, TN, TX.</B></SPAN>&nbsp; Initial Public=20
      Offerings are considered speculative investments and as such may no=
t be=20
      appropriate for every investor. If an investor chooses to participa=
te in=20
      IPOs, there are certain restrictions that apply.&nbsp;&nbsp; <B><SP=
AN=20
      style=3D"COLOR: red">Flipping </SPAN>- </B>The first time an invest=
or sells
      their shares within the first 30 days the issue is trading in the=20
      secondary market, that investor will not be allocated shares for th=
e next=20
      90 days following the sale.&nbsp; The second time that investor =93=
flips,&quot;=20
      they will not be allocated IPO shares for 180 days.&nbsp; The third=
 time=20
      that investor =93flips,&quot; they lose their IPO allocations perma=
nently.<SPAN=20
      style=3D"COLOR: red">&nbsp; <B>Transferring shares</B></SPAN><B><sp=
an style=3D"color: red">
      </span>- </B>If the=20
      investor transfers IPO shares out of their account within the first=
 30=20
      days the issue is trading in the secondary market, they will perman=
ently=20
      lose their IPO allocations.&nbsp; <B>Beta investors will be chosen =
from=20
      all the applicants based on their income, net worth and investing=20
      experience.&nbsp;</B>  Beta Test open only to those 21 years of age=
 or
      older. IPO shares will only be allocated from transactions in=20
      which eMedsecurities participates in the underwriting.&nbsp; A0009-=
1-A2</FONT>
      <p><FONT face=3DArial size=3D1>
      eMedsecurities, Inc.&nbsp;&nbsp; Member NASD&nbsp; SIPC.&nbsp; </FO=
NT></p>
    </TD></TR></TBODY></TABLE></DIV></BODY></HTML>


